We are pleased to be attending Formulation and Delivery US, an in-person event, taking place on October 11-12, 2022 in San Diego, USA.
Join us and other leaders, experts and researchers at Formulation & Delivery US: In-Person, connecting global pharma, biotech and academia for high-level discussions on the latest innovations for biopharmaceutical development.
We will be hosting a workshop at the event: Can SMIs transform inhaled biologics development? View the agenda here.
Standard nebulisers are often unsuitable for commercial inhaled biologic products. We will be exploring next-generation how Soft Mist Inhalers (SMIs) can enhance performance for inhaled biologics and cut time-to-market.
If you are able to join us, the workshop will take place on October 11th at 09.20.
At Recipharm, we offer a fully integrated service for developing and manufacturing inhalation drug products and devices to the global pharmaceutical market, including pressurised Metered Dose Inhalers (pMDIs), Soft Mist Inhalers (SMIs), Dry Powder Inhalers (DPIs), unit dose and multi dose nasal sprays.
We have a long history in inhalation device design, development and manufacturing. By developing inhalation products with the device and commercial manufacture in mind we minimise hurdles and reduce time to market.
If you would like to discover more about Recipharm and how we can support your inhalation drug products and device requirements, we’d be happy to meet and discuss this with you at the event.